Tag: alzheimer’s disease (AD)

pathology image of a Lewy body inclusion
February 15, 2024/Brain Health

Lewy Body Pathology Linked to Cerebral Amyloid Angiopathy in Alzheimer’s Disease Patients

Recognizing this association aids risk assessment before starting novel immunotherapies


Microglial Immunometabolism Endophenotypes Implicated in Sex Differences in Alzheimer’s Disease

Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches

Light trails coming from African American’s head

Blood-Based Biomarkers for Alzheimer’s Disease in Women (Podcast)

Research project aims to pinpoint biomarkers that could speed diagnosis


An All-Fronts Approach to Understanding and Overcoming Alzheimer’s Disease

A conversation with Feixiong Cheng, PhD, about his wide-ranging research initiatives


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy


Does Sleep Dysfunction Help Explain Sex Differences in Alzheimer’s Incidence and Progression?

Novel research is comparing sleep measures to biomarkers of neurodegeneration


Pilot Study to Target Sex-Based Differences in Alzheimer’s Disease

Plasma proteome analysis aimed at identifying candidate blood-based biomarkers in women

April 13, 2023/Brain Health

Markers of Metabolic Syndrome Linked to Cognitive Decline in MCI and Alzheimer’s

High plasma ApoA1 and TG/HDL-C ratio predict faster progression

22-NEU-3482371 Alzheimers-brain-650×450
January 12, 2023/Brain Health

Does Peripheral Inflammation Drive Alzheimer’s Disease Progression?

New research explores the role of immune cell and blood-brain barrier changes


Deep Learning Framework Unveiled for Identifying Risk Genes and Drug Targets in Alzheimer’s Disease

Open-source artificial intelligence technology uses human genetic data to find candidate drugs

December 13, 2022/Geriatrics

What’s the State of Anti-Amyloid Therapy in the Wake of Initial Clarity AD Findings?

Experts weigh in on the amyloid hypothesis and how to use lecanemab if approved

BackPage 1 of 3Next